Volatile organic compounds of lung cancer and possible biochemical pathways.

@article{Hakim2012VolatileOC,
  title={Volatile organic compounds of lung cancer and possible biochemical pathways.},
  author={Meggie Hakim and Yoav Y. Broza and Orna Barash and Nir Peled and Michael Phillips and Anton Amann and Hossam Haick},
  journal={Chemical reviews},
  year={2012},
  volume={112 11},
  pages={
          5949-66
        }
}
Biochemical Pathways Meggie Hakim,† Yoav Y. Broza,† Orna Barash,† Nir Peled,‡ Michael Phillips, Anton Amann, and Hossam Haick*,† †The Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, TechnionIsrael Institute of Technology, Haifa 32000, Israel ‡The Thoracic Cancer Research and Detection Center, Sheba Medical Center, Tel-Aviv University, Tel-Aviv 52621, Israel Menssana Research, Inc., Fort Lee, New Jersey 07024, United States Breath Research Institute, Austrian… 

Figures and Tables from this paper

Volatile Organic Compounds Expression in Different Cell Types: An In Vitro Approach
TLDR
The present work reviews the current advances in VOCs research in relation with in vitro cell cultures and suggests one possible approach for elucidating the biochemical background of other volatile biomarkers specific to a certain biological process is the in vitro headspace investigation of cell lines.
A Review of Exhaled Volatile Organic Compounds as Biomarkers for Thoracic Malignancies
TLDR
There is considerable evidence to support the diagnostic utility of VOCs, but the lack of standardization and external validation in large independent cohorts remain key barriers to clinical translation; efforts to address these limitations are currently underway.
Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications
TLDR
Since VOC production is reliant on metabolic activities, when combined with currently available methods, VOC analysis may identify within a group of patients with flow cytometric or molecular evidence of residual disease those most at risk for disease relapse.
Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients
TLDR
An attempt to use VOCs from exhaled breath and oral cavity air as biomarkers for oral squamous cell carcinoma (OSCC) patients showed that aldehydes present in the oral cavity might constitute potential OSCC biomarkers.
Analyses of lung cancer-derived volatiles in exhaled breath and in vitro models
TLDR
A mini review of recent human studies that have attempted to identify lung cancer-derived volatiles in exhaled breath of patients and the metabolic processes of lung cancer that could be responsible for the endogenous synthesis of these VOCs are highlighted to pinpoint the protein-encoding genes involved in these pathways.
Elucidation of Biochemical Pathways Underlying VOCs Production in A549 Cells
TLDR
Based on the absolute quantification data, trans-2-hexenol increased in parallel with number of A549 cancer cells incubated, and the qPCR data implies that ADH1c potentially plays an important role in the conversion into trans- 2- Hexenol, a novel lipid peroxidation product from animal cells.
Volatile fingerprints of cancer specific genetic mutations.
Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography–mass spectrometry
TLDR
The results demonstrate that a GC–MS metabolomics-based approach for analysis of VOCs is a valuable strategy for identifying new and specific biomarkers that may improve BC diagnosis and validate the validation of volatile signature found for BC cell lines in biofluids from BC patients.
Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis
TLDR
The present text reviews the advances made in the last 10 years in lung cancer research making use of the metabolomics strategies, particularly concerning metabolite profiling of human biofluids, expected to reflect the deviant metabolic behavior of lung tumors.
A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
TLDR
A database of 125 reliably identified VOCs previously reported for human healthy and diseased cells was assembled and their potential origin is discussed, and potential volatile biomarkers for future validation are suggested.
...
...

References

SHOWING 1-10 OF 222 REFERENCES
Determination of volatile products of human colon cell line metabolism by GC/MS analysis
TLDR
Compounds that are present in the breath, the blood and the tissue of patients represent the differences and they can serve as new biomarker for colon cancer in future.
Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
TLDR
The findings demonstrate that certain compounds can be cancer cell derived and thus may be indicative of the presence of a tumor.
Detection of lung cancer with volatile markers in the breath.
TLDR
Compared to healthy volunteers, patients with primary lung cancer had abnormal breath test findings that were consistent with the accelerated catabolism of alkanes and monomethylated alkanes, and a predictive model employing nine VOCs exhibited sufficient sensitivity and specificity to be considered as a screen for lung cancer in a high-risk population such as adult smokers.
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro
TLDR
The findings demonstrate that certain volatile compounds can be cancer-cell derived and thus indicative of the presence of a tumor, whereas other compounds are not released but seem to be consumed by CALU-1 cells.
Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells.
TLDR
Analysis of volatile organic compounds in NCI-H1666 cells indicates that the consumption of certain VOCs is commonly observed while their release shows cell line-restricted patterns, whose underlying causes are unknown.
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study
TLDR
VOC analysis could be used as a complementary test for the early diagnosis of lung cancer and its possible use in the follow-up of operated patients cannot be recommended on the basis of the results of the short-term nested study.
Breath gas aldehydes as biomarkers of lung cancer
TLDR
Sensitivity and specificity of this method were comparable to the diagnostic certitude of conventional serum markers and CT imaging and noninvasive recognition of lung malignancies may be realized if analytical skills, biochemical knowledge and medical expertise are combined into a joint effort.
TD-GC-MS Analysis of Volatile Metabolites of Human Lung Cancer and Normal Cells In vitro
TLDR
Data suggest that certain groups of VOCs may be preferentially associated with the transformed phenotype, which could be used in future screens as biomarkers for the early detection of lung cancer.
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
  • N. Sládek
  • Biology
    Journal of biochemical and molecular toxicology
  • 2003
TLDR
The absence of a fully functional first category aldehyde dehydrogenase results in a gross pathological phenotype in the absence of any insult, whereas the lack of a functional second category aLDNase is ordinarily of no consequence with respect to gross phenotype, but is of consequence in that regard when the organism is subjected to a relevant insult.
...
...